Rein Therapeutics Inc. (RNTX)

Rein Therapeutics Inc. (RNTX) is a healthcare company (biotechnology) based in the United States. The share price is $0.34, down 14.20% on the day, which values the company at $29.61M. Price as of 17 Nov 2026, 18:21 UTC, from Yahoo Finance.

Key facts

Share price
$0.34−14.20% today
Market value
$29.61M
200-week average
$2.0583% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Rein Therapeutics Inc. in more detail

It sits 83% below its 200-week average of $2.05.

Worth checking: Share count keeps rising.

1 of the superinvestors tracked here hold RNTX, including Richard Mashaal (0.0% of the portfolio).

Superinvestors holding RNTX

1 of the investors tracked here report a position in their latest 13F filing.

Rein Therapeutics Inc. (RNTX): questions and answers

What is Rein Therapeutics Inc.'s market cap?

Rein Therapeutics Inc. is valued at $29.61M at a share price of $0.34.

Is RNTX above its 200-week moving average?

No. RNTX is 83.3% below its 200-week average of $2.05. Long-term investors watch that line because strong companies rarely trade below it for long.

Does RNTX pay a dividend?

Rein Therapeutics Inc. does not currently pay a regular dividend.

Which famous investors own RNTX?

In their latest quarterly filings, Richard Mashaal (0.0% of the portfolio) hold RNTX. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Rein Therapeutics Inc. (RNTX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/RNTX

Underlying data: Yahoo Finance; company filings with the SEC.